0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R5,000 - R10,000 (2)
  • -
Status
Brand

Showing 1 - 2 of 2 matches in All Departments

Anticancer Drug Resistance - Advances in Molecular and Clinical Research (Hardcover, 1994 ed.): Lori J. Goldstein, Robert F.... Anticancer Drug Resistance - Advances in Molecular and Clinical Research (Hardcover, 1994 ed.)
Lori J. Goldstein, Robert F. Ozols
R5,474 Discovery Miles 54 740 Ships in 10 - 15 working days

Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease. We are still, however, confronted with over 500,000 cancer-related deaths per year. Clearly, the phenomenon of drug resistance is largely responsible for these failures and continues to be an area of active investigation. Since the last volume in this series, we have learned that the energy-dependent drug efflux protein, p-glycoprotein, encoded by the MDR 1 gene, is a member of a family of structurally related transport polypeptides, thus allowing us to explore the relationship between structure and function. In addition to ongoing well designed clinical trials aimed at reversing MDR mediated drug resistance, the first gene therapy studies with the MDR 1 gene retrovirally transduced into human bone marrow cells are about to be initiated. Although MDR is currently the most understood mechanism of drug resistance, we are uncovering increasing knowledge of alternative molecular and biochemical mechanisms of drug resistance to antimetabolites, cisplatin and alkylating agents and developing new strategies for circumventing such resistance. It is clear that drug resistance is complex, and many mechanisms exist by which cancer cells may overcome the cytotoxicity of our known chemotherapeutic agents. As our understanding of each of these mechanisms expands, well designed models will be necessary to test laboratory hypotheses and determine their relationship to drug resistance in humans. It is this integration of basic science and clinical investigation that will both advance our scientific knowledge and result in the improvement of cancer therapy.

Anticancer Drug Resistance - Advances in Molecular and Clinical Research (Paperback, Softcover reprint of the original 1st ed.... Anticancer Drug Resistance - Advances in Molecular and Clinical Research (Paperback, Softcover reprint of the original 1st ed. 1994)
Lori J. Goldstein, Robert F. Ozols
R5,433 Discovery Miles 54 330 Ships in 10 - 15 working days

Over the last 50 years, drug development and clinical trials have resulted in successful complete responses in diseases such as childhood leukemia, testicular cancer and Hodgkin's disease. We are still, however, confronted with over 500,000 cancer-related deaths per year. Clearly, the phenomenon of drug resistance is largely responsible for these failures and continues to be an area of active investigation. Since the last volume in this series, we have learned that the energy-dependent drug efflux protein, p-glycoprotein, encoded by the MDR 1 gene, is a member of a family of structurally related transport polypeptides, thus allowing us to explore the relationship between structure and function. In addition to ongoing well designed clinical trials aimed at reversing MDR mediated drug resistance, the first gene therapy studies with the MDR 1 gene retrovirally transduced into human bone marrow cells are about to be initiated. Although MDR is currently the most understood mechanism of drug resistance, we are uncovering increasing knowledge of alternative molecular and biochemical mechanisms of drug resistance to antimetabolites, cisplatin and alkylating agents and developing new strategies for circumventing such resistance. It is clear that drug resistance is complex, and many mechanisms exist by which cancer cells may overcome the cytotoxicity of our known chemotherapeutic agents. As our understanding of each of these mechanisms expands, well designed models will be necessary to test laboratory hypotheses and determine their relationship to drug resistance in humans. It is this integration of basic science and clinical investigation that will both advance our scientific knowledge and result in the improvement of cancer therapy.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Casio LW-200-7AV Watch with 10-Year…
R999 R884 Discovery Miles 8 840
Professor Dumbledore Wizard Wand - In…
 (7)
R808 Discovery Miles 8 080
600ml Shake Infuser Water Bottle
R75 Discovery Miles 750
Salton 3 Bar Heater
R613 Discovery Miles 6 130
Alcolin Super Glue 3 X 3G
R64 Discovery Miles 640
Monami Retractable Crayons (12 Colours)
 (1)
R83 R66 Discovery Miles 660
Bennett Read Steam Iron (2200W)
R592 Discovery Miles 5 920
Ecoflow River 2 Portable Power Station
R7,999 R3,934 Discovery Miles 39 340
Elecstor 18W In-Line UPS (Black)
R999 R404 Discovery Miles 4 040
Golf Groove Sharpener (Black)
R249 Discovery Miles 2 490

 

Partners